Search
中/EN
Contact/Message
Home
central pharmacy
Policies
Medical Institution
Franchise
Innovate
Recruit
News
Search
Home
central pharmacy
Policies
Medical Institution
Franchise
Innovate
Recruit
News
中/EN
Contact/Message
Innovate
Your current position:
Home
Innovate
International innovative drugs
Sotyktu
Sotyktu
departments:
皮肤科
drug:
片剂
Active:
deucravacitinib
indication:
治疗中度至重度斑块牛皮癣
Licensor:
Bristol-Myers Squibb Company
Approved Country/Region:
FDA
Approval time:
2022-09-09